Neurotoxic amyloidogenic peptides in the proteome of sars-cov2: potential implications for neurological symptoms in covid-19

HIGHLIGHTS

• who: Mirren Charnley from the Department Swinburne University of Technology, Hawthorn, VIC, Australia have published the paper: Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
• what: As the proteome of SARS-CoV-1 and SARS-CoV-2 possess many similarities18, the authors propose amyloid nanofibrils formed from proteins in SARS-CoV-2 may be implicated in the neurological symptoms in COVID-19. The mechanisms of cell death in neurodegenerative diseases are complex and can vary between different diseases48, and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.